Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glypromate in patients undergoing coronary artery bypass graft surgery
ISRCTN67437862Phase 2Completed
- Sponsor
- Neuren Pharmaceuticals Limited
- Start
- Sep 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glypromate in coronary arteriosclerosis (5 arms), sponsored by Neuren Pharmaceuticals Limited. Primary endpoint: Pharmacokinetics of Glypromate. Started Sep 2005; status: completed.
02
Drugs
glypromate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ISRCTN67437862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN67437862.